Mealey's (February 19, 2020, 2:42 PM EST) -- PHILADELPHIA — A federal judge in Pennsylvania on Feb. 14 ruled that a lead plaintiff in a securities class action lawsuit against a generic drug company and certain of its current and former executive officers has failed to sufficiently plead its federal securities law claims pertaining to the defendants’ alleged involvement in an illegal price-fixing scheme with competitors (Alexandre Pelletier v. Endo International PLC, et al., No. 17-5114, E.D. Pa., 2020 U.S. Dist. LEXIS 26296)....